hydroquinone has been researched along with Disease Models, Animal in 15 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroquinone (HQ) is an environmental contaminant which causes immune toxicity." | 5.37 | In vivo hydroquinone exposure alters circulating neutrophil activities and impairs LPS-induced lung inflammation in mice. ( de Lima, WT; de Melo Loureiro, AP; de Oliveira, TF; Farsky, SH; Filho, Wdos R; Hebeda, CB; Ribeiro, AL; Santos, AM; Shimada, AL, 2011) |
| " This efficient route enabled to scale up the synthesis of an orally bioavailable glycine antagonist showing outstanding in vivo anti-hyperalgesic activity in different animal models of sustained inflammation and chronic neuropathic pain." | 3.74 | Chiral tetrahydroquinoline derivatives as potent anti-hyperalgesic agents in animal models of sustained inflammation and chronic neuropathic pain. ( Alvaro, G; Barnaby, RJ; Bertani, B; Corsi, M; Di Fabio, R; Donati, D; Gentile, G; Giacobbe, S; Pentassuglia, G; Pizzi, DM; Quartaroli, M; Ratti, E; Spada, S; Vitulli, G, 2007) |
| "The two autoimmune diseases are not only linked by a concordance of clinical presentations and an autoimmune/oxidative stress-mediated toxicity pathogenesis but also by an apparent biochemical commonality." | 1.51 | Vitiligo and Hashimoto's thyroiditis: Autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune/oxidative stress-mediated toxicity pathogenesis. ( Bellanti, JA; Calderone, R; Li, D; Liang, G, 2019) |
| "We established a mouse model of contact hypersensitivity (CHS) to hydroquinone (HQ), a widespread chemical in our environment." | 1.46 | Mouse Model of Hydroquinone Hypersensitivity via Innate and Acquired Immunity and its Promotion by Combined Reagents. ( Bando, K; Endo, Y; Kuroishi, T; Sasaki, K; Sugawara, S; Takano-Yamamoto, T; Tanaka, Y, 2017) |
| "Animals were subjected to transient middle cerebral artery occlusion for 120 min." | 1.43 | Hydroquinone Strongly Alleviates Focal Ischemic Brain Injury via Blockage of Blood-Brain Barrier Disruption in Rats. ( Cho, JH; Chun Yan, B; Ha Park, J; Her, S; Hoon Choi, J; Hwi Cho, J; Hye Kim, I; Hyeon Ahn, J; Hyun Lee, C; Jin Tae, H; Jun Kang, I; Kim, YM; Koo Hwang, I; Kwon, SH; Kwon, YG; Kyu Park, O; Lee, JC; Ryoo, S; Su Kim, J; Won Kim, D; Won, MH; Yoo, KY; Youl Cho, J, 2016) |
| "Hydroquinone (HQ) is an environmental contaminant which causes immune toxicity." | 1.37 | In vivo hydroquinone exposure alters circulating neutrophil activities and impairs LPS-induced lung inflammation in mice. ( de Lima, WT; de Melo Loureiro, AP; de Oliveira, TF; Farsky, SH; Filho, Wdos R; Hebeda, CB; Ribeiro, AL; Santos, AM; Shimada, AL, 2011) |
| "In patients with tuberous sclerosis complex (TSC), a wide range of neurologic abnormalities develop, including mental retardation and seizures." | 1.32 | Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex. ( Baraban, SC; Barbaro, NM; Dinday, MT; Takahashi, DK, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Li, D | 1 |
| Liang, G | 1 |
| Calderone, R | 1 |
| Bellanti, JA | 1 |
| Hsieh, PW | 1 |
| Chen, WY | 1 |
| Aljuffali, IA | 1 |
| Chen, CC | 1 |
| Fang, JY | 1 |
| Yamada, S | 1 |
| Koyama, T | 1 |
| Noguchi, H | 1 |
| Ueda, Y | 1 |
| Kitsuyama, R | 1 |
| Shimizu, H | 1 |
| Tanimoto, A | 1 |
| Wang, KY | 1 |
| Nawata, A | 1 |
| Nakayama, T | 1 |
| Sasaguri, Y | 1 |
| Satoh, T | 1 |
| Ha Park, J | 1 |
| Yoo, KY | 1 |
| Hye Kim, I | 1 |
| Cho, JH | 3 |
| Lee, JC | 2 |
| Hyeon Ahn, J | 1 |
| Jin Tae, H | 1 |
| Chun Yan, B | 1 |
| Won Kim, D | 1 |
| Kyu Park, O | 1 |
| Kwon, SH | 1 |
| Her, S | 1 |
| Su Kim, J | 1 |
| Hoon Choi, J | 1 |
| Hyun Lee, C | 1 |
| Koo Hwang, I | 1 |
| Youl Cho, J | 1 |
| Hwi Cho, J | 1 |
| Kwon, YG | 1 |
| Ryoo, S | 1 |
| Kim, YM | 2 |
| Won, MH | 2 |
| Jun Kang, I | 1 |
| Bando, K | 1 |
| Tanaka, Y | 1 |
| Kuroishi, T | 1 |
| Sasaki, K | 1 |
| Takano-Yamamoto, T | 1 |
| Sugawara, S | 1 |
| Endo, Y | 1 |
| Park, JH | 1 |
| Park, CW | 1 |
| Ahn, JH | 1 |
| Choi, SY | 1 |
| Shin, MC | 1 |
| Lee, TK | 1 |
| Kim, IH | 1 |
| Kim, YH | 1 |
| Kim, JD | 1 |
| Tae, HJ | 1 |
| Shin, BN | 1 |
| Bae, EJ | 1 |
| Chen, BH | 1 |
| Kang, IJ | 1 |
| Ribeiro, AL | 1 |
| Shimada, AL | 1 |
| Hebeda, CB | 1 |
| de Oliveira, TF | 1 |
| de Melo Loureiro, AP | 1 |
| Filho, Wdos R | 1 |
| Santos, AM | 1 |
| de Lima, WT | 1 |
| Farsky, SH | 1 |
| Takahashi, DK | 1 |
| Dinday, MT | 1 |
| Barbaro, NM | 1 |
| Baraban, SC | 1 |
| Espinosa-Heidmann, DG | 1 |
| Suner, IJ | 1 |
| Catanuto, P | 1 |
| Hernandez, EP | 1 |
| Marin-Castano, ME | 1 |
| Cousins, SW | 1 |
| Di Fabio, R | 1 |
| Alvaro, G | 1 |
| Bertani, B | 1 |
| Donati, D | 1 |
| Pizzi, DM | 1 |
| Gentile, G | 1 |
| Pentassuglia, G | 1 |
| Giacobbe, S | 1 |
| Spada, S | 1 |
| Ratti, E | 1 |
| Corsi, M | 1 |
| Quartaroli, M | 1 |
| Barnaby, RJ | 1 |
| Vitulli, G | 1 |
| Kimura, T | 1 |
| Kalish, RS | 1 |
| Wood, JA | 1 |
| Lübbe, AS | 1 |
| Alsip, NL | 1 |
| Harris, PD | 1 |
| Garrison, RN | 1 |
1 review available for hydroquinone and Disease Models, Animal
| Article | Year |
|---|---|
Studies on development of hairless descendants of Mexican hairless dogs and their usefulness in dermatological science.
Topics: Animals; Blood Cell Count; Breeding; Dermatitis, Allergic Contact; Dermatology; Dihydroxyphenylalani | 1996 |
14 other studies available for hydroquinone and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Vitiligo and Hashimoto's thyroiditis: Autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune/oxidative stress-mediated toxicity pathogenesis.
Topics: Animals; Autoimmune Diseases; Autoimmunity; Benzoquinones; Disease Models, Animal; Hashimoto Disease | 2019 |
Co-drug strategy for promoting skin targeting and minimizing the transdermal diffusion of hydroquinone and tranexamic acid.
Topics: Administration, Cutaneous; Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Drug Com | 2013 |
Marine hydroquinone zonarol prevents inflammation and apoptosis in dextran sulfate sodium-induced mice ulcerative colitis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Colitis, Ulcerative; | 2014 |
Hydroquinone Strongly Alleviates Focal Ischemic Brain Injury via Blockage of Blood-Brain Barrier Disruption in Rats.
Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Cytoprotection; Disease Models, Animal; Glucos | 2016 |
Mouse Model of Hydroquinone Hypersensitivity via Innate and Acquired Immunity and its Promotion by Combined Reagents.
Topics: Adaptive Immunity; Animals; Cytokines; Dermatitis, Contact; Disease Models, Animal; Hydroquinones; I | 2017 |
Neuroprotection and reduced gliosis by pre- and post-treatments of hydroquinone in a gerbil model of transient cerebral ischemia.
Topics: Animals; Antigens, Nuclear; Astrocytes; Brain Ischemia; Disease Models, Animal; Gerbillinae; Gliosis | 2017 |
In vivo hydroquinone exposure alters circulating neutrophil activities and impairs LPS-induced lung inflammation in mice.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cell Adhesion Molecules; Cell Movement; Disease Models, Anima | 2011 |
Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex.
Topics: Animals; Astrocytoma; Brain Neoplasms; Cerebral Cortex; Disease Models, Animal; Female; Hydroquinone | 2004 |
Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD.
Topics: Animals; Basement Membrane; Bruch Membrane; Cotinine; Dietary Fats; Disease Models, Animal; Extracel | 2006 |
Chiral tetrahydroquinoline derivatives as potent anti-hyperalgesic agents in animal models of sustained inflammation and chronic neuropathic pain.
Topics: Animals; Biological Availability; Disease Models, Animal; Glycine; Hydroquinones; Hyperalgesia; Infl | 2007 |
Sensitization of mice to paraphenylenediamine and structurally-related compounds: adjuvant effects of vitamin A supplementation.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Animals; Cell Division; Coloring Agents; Dermatit | 1995 |
Altered endothelial mechanisms blunt skeletal muscle microcirculatory responses to live E. coli sepsis in 1K1C hypertension.
Topics: Acetylcholine; Animals; Disease Models, Animal; Endothelium, Vascular; Escherichia coli Infections; | 1992 |